Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 36 min ago
Peer-reviewedCC BY-NC 4.0Bio-protocol

Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo

  1. 1Section of Pulmonary Diseases, Critical Care and Environmental Medicine, John W. Deming Department of Medicine, Tulane University, New Orleans, LA, USA
  2. 2Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
  3. 3Section of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, Baylor College of Medicine, Houston, TX, USA

Abstract

Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states.

Key features

• Programmable sesRNAs convert endogenous RNA signatures into ADAR-dependent EGFP translation without requiring a new transgenic mouse line.

• Includes candidate sensor design, in vitro validation of target-dependent EGFP expression in HEK293T cells, and AAV6.2FF production and purification using a heparin column.

• Supports in vivo labeling of AT2, AT1, and Sprr1a-positive transitional alveolar epithelial cells in mice.

• Extends the workflow to human IPF PCLS for ex vivo assessment of SPRR1A-guided reporter expression in KRT17+KRT5- aberrant basaloid cells.

Related

  1. Single-Cell Transcriptomic Analysis Identifies a Translation/RBP-Related Fibroblast Signature for Drug Repurposing in Idiopathic Pulmonary Fibrosis
    Yongkang Qiao, Chaoyue Cui, Yanhong Han +3
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  2. Pulmonary Fibroblast Heterogeneity and Functional Remodeling in Idiopathic Pulmonary Fibrosis: State Persistence and Reversibility
    Lincha Tian, Xinru Feng, Bo Xiao +5
    International Journal of Molecular SciencesPeer-reviewedCC BY 4.0General biochemistryCrossref
  3. A mucosal barrier injury related six gene transcriptomic signature associated with ulcerative colitis using machine learning and public transcriptomic data
    Sen He, Pingliang Sun, Xiaoxin Duan
    PLOS OnePeer-reviewedCC BYFull textMolecular biology & gene regulationBioinformatics & computational biologyPLOSEurope PMCPMC
  4. Integrated transcriptomic analysis identifies an AKT1-associated metabolic-inflammatory signature in osteoporosis.
    Chenglong Bao, Ronggui Hu
    Clinical and experimental medicinePeer-reviewedCC BY-NC-NDFull textMolecular biology & gene regulationEurope PMC
  5. IPF distal lung epithelial cells acquire a DNA methylation signature consistent with activation of basal cell transcriptional programs
    A. C. Colvard, S. A. Iantorno, I. P. Gaona +11
    bioRxivPreprintCC BY-NCFull textMolecular biology & gene regulationbioRxiv
BibTeX
@article{zheng2026transcriptomic,
  title = {{Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo}},
  author = {Zhen Zheng and Chun-sun Jiang and Dan Shan and Chao He and Ivan O. Rosas and Joseph A. Lasky and Victor J. Thannickal and Yong Zhou},
  journal = {Bio-protocol},
  year = {2026},
  month = nov,
  doi = {10.21769/bioprotoc.5863},
  url = {https://doi.org/10.21769/bioprotoc.5863},
  note = {CC BY-NC 4.0},
}
RIS
TY  - JOUR
TI  - Transcriptomic Signature-Guided EGFP Labeling of Alveolar Epithelial Cells via RNA Sensing in Mouse Lungs In Vivo and Human Idiopathic Pulmonary Fibrosis Lung Slices Ex Vivo
AU  - Zhen Zheng
AU  - Chun-sun Jiang
AU  - Dan Shan
AU  - Chao He
AU  - Ivan O. Rosas
AU  - Joseph A. Lasky
AU  - Victor J. Thannickal
AU  - Yong Zhou
PY  - 2026
DA  - 2026/11/05
JO  - Bio-protocol
DO  - 10.21769/bioprotoc.5863
UR  - https://doi.org/10.21769/bioprotoc.5863
AB  - Single-cell RNA sequencing has revealed transient and disease-associated alveolar epithelial states that are difficult to access with conventional transgenic approaches. Here, we describe a programmable RNA-sensing workflow based on CellREADR [cell access through RNA sensing by endogenous adenosine deaminases acting on RNA (ADAR)] to couple a selected cellular RNA signature to enhanced green fluorescent protein (EGFP) translation. The protocol covers sequence-encoded sensing RNA (sesRNA) design and cloning, in vitro validation of sesRNA-dependent EGFP expression in HEK293T cells, production and heparin-column purification of adeno-associated virus variant 6.2FF (AAV6.2FF), delivery to mouse lungs, and application to human idiopathic pulmonary fibrosis (IPF) precision-cut lung slices (PCLS). Sensors targeting Sftpc, Pdpn, or Sprr1a can be used to label alveolar type 2, alveolar type 1, and injury-induced Krt8+ alveolar differentiation intermediate cells in mice and KRT17+KRT5- aberrant basaloid cells in humans, respectively. Because cell specificity is programmed by the sensor sequence rather than a cell type–specific promoter or newly generated mouse line, this approach can be rapidly adapted to emerging transcriptomic targets in both experimental mouse models and human lung tissues, enabling cross-species validation and translational investigation of disease-associated epithelial states.  Key features  • Programmable sesRNAs convert endogenous RNA signatures into ADAR-dependent EGFP translation without requiring a new transgenic mouse line.  • Includes candidate sensor design, in vitro validation of target-dependent EGFP expression in HEK293T cells, and AAV6.2FF production and purification using a heparin column.  • Supports in vivo labeling of AT2, AT1, and Sprr1a-positive transitional alveolar epithelial cells in mice.  • Extends the workflow to human IPF PCLS for ex vivo assessment of SPRR1A-guided reporter expression in KRT17+KRT5- aberrant basaloid cells.
SN  - 2331-8325
ER  -